The AI operating layer for healthcare - governed, agentic, and built to earn a clinician's trust before it earns a headline.
Healthcare does not lack data. It drowns in it - faxes, PDFs, scanned charts, prior-authorization letters, and clinical notes that no human can process fast enough. Autonomize AI, a company founded in Austin in 2022 by Ganesh Padmanabhan and Kris Nair, built its business on the least glamorous corner of that problem: turning the mess into something a machine can actually act on, without taking the clinician out of the decision.
The company calls its product an "AI operating layer for healthcare." In plain terms, it is a platform that drops pre-built, governed AI agents into the workflows that eat up a health plan's day - utilization review, prior authorization, benefits coordination, care management, and clinical chart review. The pitch is not that AI replaces the reviewer. It is that the AI does the reading, the sorting, and the drafting, and a person stays in the lead on anything that matters.
That framing - "human-in-the-lead" rather than the more familiar "human-in-the-loop" - is a small phrase that carries the company's whole worldview. In a field where a wrong answer can delay a cancer treatment or deny a legitimate claim, Autonomize AI has decided that trust is the product, and automation is just the mechanism.
Figures are company-reported and reflect deployments across its customer base; treat as directional rather than audited.
American healthcare loses enormous clinician time to paperwork - reviewing authorizations, hunting through charts, reconciling coverage rules against a patient's record. Autonomize AI aims those hours back at care.
The Knowledge Center organizes clinical, regulatory, and coverage information into a context graph of 10M+ concepts, so agents reason over structured intelligence instead of raw documents.
Agents draft and pre-screen prior-authorization and claims decisions, which the company says can move up to 50% faster - with a full input-to-output audit trail.
The platform reports generating more than 100,000 automated care plans a month, freeing nurses and case managers from repetitive drafting.
Audit trails, explainability, and escalation of high-risk calls to human reviewers are baked into the design - the controls enterprise IT and compliance teams demand.
The current healthcare system is no longer suited for the way care is delivered today. Automation alone is not the answer for healthcare, but accountable, human-centered AI augmentation is.
The Autonomize Intelligence Platform is assembled from four connected pieces, wired to real systems through 50+ pre-built connectors for EHRs, claims platforms, and legacy infrastructure.
A living context graph that structures healthcare data into intelligence and updates with every decision the system makes.
160+ ready-to-deploy agents and workflows drawn from production experience - not one-off proofs of concept.
A visual, low-code studio - now paired with Genie AI, which lets frontline experts design governed agents by describing them in plain English.
Real-time monitoring of business and operational metrics with full lifecycle tracing for auditability and oversight.
Autonomize AI sells to Fortune 100 health plans, providers, and life sciences organizations. The company says it runs in production at three of the five largest US health enterprises.
The business model is enterprise B2B SaaS, offered along three paths: instant deployment of pre-built agents, custom workflow development with the company's engineers, and full business-transformation consulting. Where broad AI assistants pitch a blank prompt box, Autonomize competes on a healthcare-native knowledge graph, a marketplace of production-tested agents, and governance that satisfies payers' compliance teams - positioning it against clinical-AI peers such as Cohere Health, Navina, Regard, and Innovaccer, as well as the in-house AI teams inside large insurers.
In June 2025, Autonomize AI closed a $28 million Series A, bringing total capital raised to roughly $32-36 million. Notably, the round was led by strategic healthcare investors who look a lot like its buyers - a signal that the people who would deploy the software also believed in it.
Previously worked at Dell and CognitiveScale and co-founded data company Molecula. He frames Autonomize around accountable, human-centered AI - and, per a 2026 Fortune feature, on solving real healthcare problems rather than chasing demos.
Co-founded the company in 2022 and leads its technical architecture - the knowledge graph, agent orchestration, and the governance layer that keeps deployments auditable.
In April 2026, the company appointed Dr. Sandhya Gardner as Chief Medical Officer to accelerate clinical AI adoption - a hire that underscores its bet that clinical credibility, not just engineering, decides whether healthcare AI ships.
Ganesh Padmanabhan and Kris Nair start Autonomize AI to attack healthcare's unstructured-data and administrative-burden problem.
Raises roughly $4M and ships early AI copilots for healthcare and life sciences workflows.
Valtruis, The Cigna Group Ventures, and Tau Ventures lead the round to scale the agentic orchestration platform.
Launches Version 3 of the Intelligence Platform, is named a World Economic Forum Technology Pioneer, and releases Genie AI - its natural-language agent builder.
It builds an AI-native platform that embeds governed AI agents into healthcare workflows - turning unstructured clinical, regulatory, and claims data into intelligence and automating tasks like utilization review, prior authorization, care management, and chart review.
It was founded in 2022 in Austin, Texas by Ganesh Padmanabhan (Founder & CEO) and Kris Nair (Co-Founder & CTO).
It raised a $28 million Series A in June 2025 led by Valtruis, The Cigna Group Ventures, and Tau Ventures, bringing total capital raised to roughly $32-36 million.
Fortune 100 health plans, providers, and life sciences organizations. It says it serves 3 of the 5 largest US health enterprises, with named customers and partners including Molina Healthcare, Elevance Health, Altais, Lyric, and Elligo Health Research.
It emphasizes a governed, "human-in-the-lead" approach built on a 10M+ concept clinical knowledge graph, a marketplace of 160+ production-tested agents, and full auditability - aiming to move beyond one-off automation to a trusted, enterprise-wide AI operating layer.
Profile compiled from public sources including company materials, BusinessWire, HIT Consultant, Valtruis, and Built In Austin. Metrics are company-reported and directional.